• MCL: consolidation radioimmunotherapy extends survival in unfit patients

    Almost 6 years median PFS in patients with complete response to frontline induction.

  • Bortezomib plus standard therapy for diffuse large B-cell lymphoma
    Bortezomib plus standard therapy for diffuse large B-cell lymphoma

    Findings from the REMoDL-B trial published in the Lancet Oncology.

  • DLBCL: dose-adjusted EPOCH-R more toxic than R-CHOP

    Phase 3 study fails to show progression-free or overall survival benefit.

  • The UK will not follow France in banning textured breast implants
    The UK will not follow France in banning textured breast implants

    Last week, French authorities announced a restriction on macrotextured and polyurethane-coated breast implants.

  • Aggressive lymphoma: cachexia shows sex-specific prognostic utility

    Data show correlation with changes in metabolism, immune function.

  • Primary extranodal cHL: more intensive therapy may be needed

    Data show short remission, high relapse rates, and inferior survival.

  • NHL: polatuzumab vedotin + rituximab favored in final analysis

    ROMULUS data show longer duration of action in relapsed/refractory disease.

  • AACR 2019—Umbralisib delivers 52% response rate in marginal zone lymphoma

    Data from the ongoing phase 2b UNITY-NHL trial.

  • Marginal zone lymphoma: long-term data for lenalidomide-rituximab

    Regimen switches chemotherapy for lenalidomide without compromise.

  • DLBCL: phase 3 results for frontline ibrutinib plus R-CHOP

    Numerical improvement in survival among younger patients.

  • Indolent NHL: lenalidomide-rituximab ups PFS in phase 3 trial

    54% reduction in risk of progression or death vs rituximab alone.

  • NICE approves tisagenlecleucel for B-cell lymphoma

    The treatment is to be made available under the Cancer Drugs Fund

  • Follicular lymphoma: relapse after primary radiotherapy

    Research from the International Lymphoma Radiation Oncology Group

  • Pesticides and NHL: risk is subtype- and chemical-specific

    An analysis of >300,000 agricultural workers.

  • Load more